Peakview Partners is pleased to announce it acted as exclusive M&A advisor to AlloSource in the sale of its wholly-owned subsidiary, LABS, Inc., to an undisclosed international strategic buyer.

Tom Cycyota, President and CEO of AlloSource, said “Peakview’s senior level bankers understood the important work LABS performs for the organ, eye and tissue donation industry and were dedicated to ensuring the transaction process resulted in a great outcome for AlloSource and its stakeholders. Based on our experience, we would use Peakview Partners for any future transactional needs.”LABS operates specialized laboratories in multiple locations in the U.S. The company provides laboratory services specialized for transplantation and biomedical applications, with a testing menu that includes infectious disease agent screening, histocompatibility, clinical microbiology and sterility testing. The parent company, AlloSource, has a mission to provide innovative cellular and tissue allografts to advance patient healing. It serves customers in the U.S and internationally from its Colorado facility. Learn more at www.allosource.org.